NCT02756754View on ClinicalTrials.gov

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 7, 2016

Primary Completion Date

October 4, 2018

Study Completion Date

May 10, 2019

Conditions
Primary AldosteronismAdrenal Adenoma
Interventions
DEVICE

Radiofrequency ablation

The radiofrequency system will be used as the RFA generator device standard cycle of ablation will be applied in the patient. During RFA, blood pressure, pulse and oxygen saturation will be continuously monitored.

Trial Locations (2)

31059

CHU de Toulouse, Toulouse

Unknown

CHU Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02756754 - Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism | Biotech Hunter | Biotech Hunter